NEW YORK (GenomeWeb News) - Ronald Lowy has taken over as CEO at Helicos BioSciences for Steve Lombardi, who will stay on in his roles as president of the company and member of the board of directors. Lowy has served on the board since November 2007, a post he will retain. He previously served as president and CEO of Fisher Biosciences, a division of Fisher Scientific, and held management positions at GE Medical Systems.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.